News and Trends 12 Sep 2022
Ayala Pharmaceuticals presents interim data on desmoid tumor trial
Clinical oncology company Ayala Pharmaceuticals, Inc. has announced updated, positive interim results from part A of its ongoing RINGSIDE pivotal phase 2/3 clinical trial evaluating investigational new drug AL102 in…